The Pharmacogenomic Era: Promise for Personalizing Attention Deficit Hyperactivity Disorder Therapy
- 30 April 2008
- journal article
- review article
- Published by Elsevier BV in Child and Adolescent Psychiatric Clinics of North America
- Vol. 17 (2), 475-490
- https://doi.org/10.1016/j.chc.2007.11.009
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and PharmacodynamicsClinical Pharmacology & Therapeutics, 2007
- No significant association between response to methylphenidate and genes of the dopaminergic and serotonergic systems in a sample of Brazilian children with attention‐deficit/hyperactivity disorderAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
- Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHDAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2006
- Association of 4-Repeat Allele of the Dopamine D4 Receptor Gene Exon III Polymorphism and Response to Methylphenidate Treatment in Korean ADHD ChildrenNeuropsychopharmacology, 2006
- Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHDNeuropsychopharmacology, 2005
- The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidateEuropean Neuropsychopharmacology, 2005
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPublished by American Academy of Pediatrics (AAP) ,2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Pharmacokinetic and Pharmacodynamic Drug Interactions in the Treatment of Attention-Deficit Hyperactivity DisorderClinical Pharmacokinetics, 2001
- MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISMAnnual Review of Pharmacology and Toxicology, 1997